{
    "organizations": [],
    "uuid": "a14376e799849b5825acf70d90fad8f642725387",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-metastat-announces-positive-toplin/brief-metastat-announces-positive-topline-data-showing-over-50-reduction-in-cancer-metastasis-idUSFWN1QI0U6",
    "ord_in_thread": 0,
    "title": "BRIEF-Metastat Announces Positive Topline Data Showing Over 50% Reduction In Cancer Metastasis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Metastat Inc:\n* METASTAT ANNOUNCES POSITIVE TOPLINE DATA SHOWING OVER 50% REDUCTION IN CANCER METASTASIS FROM PRECLINICAL STUDIES EVALUATING INHIBITION OF THE MAPKAPK2 KINASE PATHWAY Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-02-28T20:35:00.000+02:00",
    "crawled": "2018-03-01T21:11:06.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "metastat",
        "inc",
        "metastat",
        "announces",
        "positive",
        "topline",
        "data",
        "showing",
        "reduction",
        "cancer",
        "metastasis",
        "preclinical",
        "study",
        "evaluating",
        "inhibition",
        "mapkapk2",
        "kinase",
        "pathway",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}